rotation has moved past semis and hyperscalers into the physical layer: cooling chemistry, rack integrators, sovereign deployments. Biotech is getting a discrete bid on de-risked clinical stories, not speculative ones. The names moving fastest right now have real Tier 1 commercial traction and zero sell-side coverage. That gap closes eventually.
This content is for informational and educational purposes only. It may include third-party insights, sponsored content, or promotional material for which the creator may receive compensation. Nothing in this feed constitutes investment advice or a guarantee of returns. You are solely responsible for your own investment decisions. Always conduct your own research and exercise caution before trading. We do not guarantee the accuracy of third-party information and are not liable for any losses incurred. Past performance is not indicative of future results. Please refer to our Community Terms and Risk Disclosure Statement for details.
Post your reply